These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Objectification of pathologial processes in the region of the visual pathway by scintigraphy]. Zita G Klin Monbl Augenheilkd; 1968; 152(4):584-9. PubMed ID: 5686097 [No Abstract] [Full Text] [Related]
45. [Clinical significance of scanning of the skull using 85Sr]. Watanabe K; Katayama H; Inakura M; Koga K; Nakata S Rinsho Hoshasen; 1972 Jan; 17(1):25-37. PubMed ID: 4482037 [No Abstract] [Full Text] [Related]
46. [Scintigraphic visualization of cardiac infarct. Experimental studies of the distribution of chloromedrin-Hg203 in the tissues]. Pucci C; Ferri O; Augusti A Minerva Chir; 1971 Sep; 26(18):1011-23. PubMed ID: 5129423 [No Abstract] [Full Text] [Related]
47. [Scintigraphic evaluation of the renal surfaces in normal and pathological conditions]. Palumbo R Rev Bras Biol; 1966 Dec; 26(4):1377-86. PubMed ID: 5999435 [No Abstract] [Full Text] [Related]
48. [Contribution of isotopic nephrograms and scintigraphy to the diagnosis of vasculo-renal hypertension]. Gotta H; Pecorini V; Olivari A; Chwojnik A Ann Radiol (Paris); 1967; 10(7):481-6. PubMed ID: 5613313 [No Abstract] [Full Text] [Related]
49. [Localization of intracranial lesions using chlormerodrin Hg 203]. Stevenson C; Claure H; Asenjo A Neurocirugia; 1968; 26(1):94-104. PubMed ID: 5739601 [No Abstract] [Full Text] [Related]
51. Comparison of results of brain-scanning with technetium-99M pertechnetate and mercury-197 chlormerodrin. Stanbro WW; Murphy CF Med Ann Dist Columbia; 1967 Dec; 36(12):735-6. PubMed ID: 5237424 [No Abstract] [Full Text] [Related]
52. [Renal function in a 60-year old patient with acute erythremia (Di Guglielmo's disease). (Scintigraphy and renal and peripheral uptake curves with chloromedrin-Hg 203; clearances; nephrhography)]. Carnovale M; Martina GD; Strinati LA Policlinico Prat; 1968 May; 75(21):687-92. PubMed ID: 5259517 [No Abstract] [Full Text] [Related]
53. The use of sulphydryl containing drugs and chelating agents to reduce renal irradiation during 203Hg chlormerodrin scintigraphy. Cardinale A; De Simone GF J Nucl Biol Med; 1968; 12(3):121-7. PubMed ID: 4979240 [No Abstract] [Full Text] [Related]
54. [Usefulness of renal color scanning in pediatric pathology]. Mussa GC; Martini Mauri M; Bacolla D Nursing (Brux); 1970; 42(1):335-49. PubMed ID: 5199457 [No Abstract] [Full Text] [Related]
55. [The diagnostic importance of scanning in some diseases of the kidneys]. Epshteĭn IM; Spesivtseva VG; Zolotarev II; Shlevkov BA Sov Med; 1966 Mar; 29(3):92-9. PubMed ID: 5996182 [No Abstract] [Full Text] [Related]
56. Comparison of 99mTc-pertechnetate and 197Hg-chlormerodrin for brain scanning. Sodee DB J Nucl Med; 1968 Dec; 9(12):645. PubMed ID: 5729215 [No Abstract] [Full Text] [Related]
58. Scintiencephalography as a diagnostic tool for the detection of intracranial tumors. Morrison RT; Afifi AK J Iowa Med Soc; 1967 Jun; 57(6):566-70. PubMed ID: 6047389 [No Abstract] [Full Text] [Related]
59. [Renal scanning with radioactive mercury (Hg-203) in cystic diseases of the kidney]. Rocha-Brito R; Albuquerque J; Borges HJ; Zulian R; Otero NR Rev Paul Med; 1972 Dec; 80(5):243-8. PubMed ID: 4671595 [No Abstract] [Full Text] [Related]